Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Acta Neuropathologica Communications|July 27, 2019
Dramatic response of BRAF V600E-mutant epithelioid glioblastoma to combination therapy with BRAF and MEK inhibitor: establishment and xenograft of a cell line to predict clinical efficacyYu Kanemaru, Manabu Natsumeda, Masayasu Okada, et al.
Nature Communications|November 14, 2013
Chondroitin sulphate N-acetylgalactosaminyl-transferase-1 inhibits recovery from neural injuryKosei Takeuchi, Nozomu Yoshioka, Susumu Higa Onaga, et al.
Brain Tumor Pathology|May 20, 2025
Rapidly progressive scalp and lung metastases with fatal pneumothorax in glioblastoma, IDH-wildtype, with MET and CDK6 amplifications: a case report of clinical course and postmortem autopsy, including genetic analysisYoshihiro Tsukamoto, Manabu Natsumeda, Hiroshi Shimizu, et al.
Pediatric Blood & Cancer|January 10, 2025
Diagnosis of Leptomeningeal Disease in Diffuse Midline Gliomas by Detection of H3F3A K27M Mutation in Circulating Tumor DNA of Cerebrospinal FluidSatoshi Shibuma, Jotaro On, Manabu Natsumeda, et al.
Journal of Neuro-Oncology|January 16, 2024
Reliable detection of genetic alterations in cyst fluid DNA for the diagnosis of brain tumorsJotaro On, Manabu Natsumeda, Haruhiko Takahashi, et al.
Current Oncology (Toronto, Ont.)|April 26, 2024
Successful Multimodal Treatment of Intracranial Growing Teratoma Syndrome with Malignant FeaturesDaiken Satake, Manabu Natsumeda, Kaishi Satomi, et al.
Journal of Neurosurgery. Case Lessons|October 23, 2023
Clinical, imaging, and molecular features of radiation-induced glioblastomas developing more than 20 years after radiation therapy for intracranial germinomatous germ cell tumor: illustrative casesYoshihiro Tsukamoto, Manabu Natsumeda, Haruhiko Takahashi, et al.
Journal of Neuropathology and Experimental Neurology|November 29, 2020
GLI3 Is Associated With Neuronal Differentiation in SHH-Activated and WNT-Activated MedulloblastomaManabu Natsumeda, Hiroaki Miyahara, Junichi Yoshimura, et al.
Molecular Cell|February 5, 2025
SLFN11-mediated ribosome biogenesis impairment induces TP53-independent apoptosisAkane Ogawa, Keiichi Izumikawa, Sota Tate, et al.
Neuro-Oncology Advances|March 13, 2026
Treatment initiation by positive liquid biopsy alone in primary central nervous system lymphoma: A retrospective analysis of a multi-institutional studyMasaki Mitobe, Satoshi Shibuma, Haruhiko Takahashi, et al.
Pageof 6